Search
TT 173
go.drugbank.com/drugs/DB17717InvestigationalTT 173 is a Modified Human Tissue Factor currently being investigated to treat bleeding disorders such as hemophilia and von Willebrand disease, as well as bleeding episodes in cutaneous injuries or dental
MK-0249
go.drugbank.com/drugs/DB11910InvestigationalMK0249 has been used in trials studying the treatment of Hypopnea Syndrome, Alzheimer's Disease, Paranoid Schizophrenia, Sleep Apnea, Obstructive, and Excessive Daytime Sleepiness, among others.
PF-04691502
go.drugbank.com/drugs/DB11974InvestigationalPF-04691502 has been used in trials studying the treatment of Cancer, Breast Neoplasms, Early Breast Cancer (Phase 2), and Advanced Breast Cancer (Phase 1b).
Fluorescein lisicol
go.drugbank.com/drugs/DB12030InvestigationalFluorescein lisicol has been used in trials studying the diagnostic of Pharmacokinetics, Hepatic Cirrhosis, Hepatitis, Viral, Human, Nonalcoholic Steatohepatitis, and Non-Alcoholic Fatty Liver Disease.
Radezolid
go.drugbank.com/drugs/DB12339InvestigationalRadezolid has been used in trials studying the treatment of Abscess, Bacterial Skin Diseases, Streptococcal Infections, Infectious Skin Diseases, and Staphylococcal Skin Infections, among others.
Fiztasovimab
go.drugbank.com/drugs/DB24033InvestigationalFiztasovimab, also known as NPC‐21 and EV2038, is a monoclonal antibody. … [A278004, A278005] NPC-21 is under investigation in clinical trial NCT04225923 (A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection).
Lutetium Lu-177 DOTA-ABM-5G
go.drugbank.com/drugs/DB33946ExperimentalLutetium Lu-177 DOTA-ABM-5G is under investigation in clinical trial NCT06389123 (Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas). … Lutetium Lu-177 DOTA-ABM-5G is a biologic drug.